Medicare Enrolled

Dr. Bartley Gill, M.D., PH.D.

Internal Medicine · Sugar Land, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
7616 BRANFORD PL STE 240, Sugar Land, TX 77479
2812404313
In practice since 2014 (11 years)
NPI: 1346669066 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gill

Dr. Bartley Gill is an internal medicine in Sugar Land, TX, with 11 years in practice. Based on federal Medicare data, Dr. Gill performed 4,561 Medicare services across 2,117 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gill received a total of $171,776 from 38 pharmaceutical and/or device companies across 1073 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gill is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 7% volume in TX$ $171,776 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,561
Medicare services
Top 7% in TX for internal medicine
2,117
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~415 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-141,795$5$18
Office visit, established patient (20-29 min)481$63$171
Destruction of skin growths (warts/lesions), 1-14473$64$199
Destruction of precancerous skin growth, 1399$29$196
Tissue pathology examination, moderate complexity382$26$50
Office visit, established patient (30-39 min)333$85$253
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm187$71$226
Destruction of precancer skin growth, 15 or more growths87$100$425
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm74$87$260
New patient office visit (30-44 min)66$78$255
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm61$77$232
Steroid injection (triamcinolone)51$1$15
New patient office visit (45-59 min)50$93$392
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm36$228$745
Injection into skin growth, 1-7 growths32$31$137
Skin biopsy, tangential24$47$250
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm17$95$598
Pathology examination of tissue using a microscope, moderately low complexity13$24$50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$171,776
Total received (2018-2024)
Avg $24,539/year across 7 years
Top 1% in TX for internal medicine
38
Companies
1,073
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$139,288 (81.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,033 (10.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,455 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,906
2023
$27,963
2022
$31,576
2021
$17,995
2020
$7,517
2019
$65,458
2018
$1,360

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$136,011
E.R. Squibb & Sons, L.L.C.
$10,125
Journey Medical Corporation
$3,882
GENZYME CORPORATION
$3,519
Novartis Pharmaceuticals Corporation
$2,269
ABBVIE INC.
$1,850
Eli Lilly and Company
$1,800
Janssen Biotech, Inc.
$1,604
AbbVie, Inc.
$1,560
Regeneron Healthcare Solutions, Inc.
$1,476
Celgene Corporation
$1,151
AbbVie Inc.
$856
Galderma Laboratories, L.P.
$716
Arcutis Biotherapeutics, Inc.
$655
Amgen Inc.
$614
LEO Pharma Inc.
$601
UCB, Inc.
$527
Incyte Corporation
$515
Sun Pharmaceutical Industries Inc.
$478
PFIZER INC.
$422
Dermavant Sciences, Inc.
$351
SUN PHARMACEUTICAL INDUSTRIES INC.
$197
VYNE Pharmaceuticals Inc.
$89
Biofrontera Inc.
$76
Almirall LLC
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Ortho Dermatologics, a division of Bausch Health US, LLC
$47
EPI Health, LLC
$40
DERMIRA, INC.
$26
Janssen Scientific Affairs, LLC
$26
Medimetriks Pharmaceuticals, Inc.
$24
Genentech USA, Inc.
$24
Bayer HealthCare Pharmaceuticals Inc.
$24
SANOFI-AVENTIS U.S. LLC
$22
Verrica Pharmaceuticals Inc.
$22
Kyowa Kirin, Inc.
$19
MAYNE PHARMA COMMERCIAL LLC
$16
Mylan Pharmaceuticals Inc.
$14
Top 3 companies account for 87.3% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · Absorica LD · Accutane · Ameluz · BLU-U · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · JUBLIA · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · POTELIGEO · QBREXZA · Qbrexza · REMICADE · RINVOQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · TRILUMA · TWYNEO · TargaDox · Tremfya · VTAMA · Winlevi · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in TX.

Equivalent to $3,766 per 100 Medicare services performed
Looking for a internal medicine in Sugar Land?
Compare internal medicines in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,268
Per 100K population
263.8
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gill is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (speaking/promotional, top 1%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gill experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Gill performed 1,795 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gill receive payments from pharmaceutical companies?
Yes. Dr. Gill received a total of $171,776 from 38 companies across 1,073 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gill's costs compare to other internal medicines in Sugar Land?
Dr. Gill's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →